Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential to help in treating many different types of cancers. Here are some highlights from data and learnings presented in Chicago.
ASCO17: Exploring the Past, Present, and Future of Immunotherapy
Read Previous Article
ASCO17: Day 2 Immunotherapy Highlights
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and may help protect against cancer.
Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or fails in certain patients.